Medivation Inc. (MDVN): Today's Featured Health Care Leader

Medivation ( MDVN) pushed the Health Care sector higher today making it today's featured health care leader. The sector as a whole closed the day down 0.9%. By the end of trading, Medivation rose 91 cents (1%) to $95.58 on light volume. Throughout the day, 330,600 shares of Medivation exchanged hands as compared to its average daily volume of 742,800 shares. The stock ranged in a price between $94.09-$95.78 after having opened the day at $94.51 as compared to the previous trading day's close of $94.67. Other companies within the Health Care sector that increased today were: Aoxing Pharmaceutical Company ( AXN), up 24%, Astex Pharmaceuticals ( ASTX), up 13.5%, Durect Corporation ( DRRX), up 12.6%, and Onyx Pharmaceuticals ( ONXX), up 11.7%.

Medivation, Inc., a biopharmaceutical company, focuses on developing novel small molecule drugs for the treatment of serious diseases in the United States and Europe. Medivation has a market cap of $3.45 billion and is part of the drugs industry. Shares are up 105.3% year to date as of the close of trading on Thursday. Currently there are eight analysts that rate Medivation a buy, no analysts rate it a sell, and one rates it a hold.

TheStreet Ratings rates Medivation as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including poor profit margins, weak operating cash flow and generally poor debt management.

On the negative front, Staar Surgical ( STAA), down 25.7%, Somaxon Pharmaceuticals ( SOMX), down 13%, pSivida ( PSDV), down 12%, and Novavax ( NVAX), down 10.8%, were all laggards within the health care sector with Gilead ( GILD) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).